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Background: To examine risk factors for asthma patients’ emergency room (ER) visits in a well organized asthma
care setting.
Methods: A random sample of 344 asthma patients from a Pulmonary Clinic of a University Hospital were followed
through medical records from 1995 to 2006. All the ER visits due to dyspnea, respiratory infections, chest pain, and
discomfort were evaluated.
Results: The mean age of the study population was 56 years (SD 13 years), 72% being women. 117 (34%) of the
patients had had at least one ER visit during the follow-up (mean 0.5 emergency visits per patient year, range 0–7).
Asthma exacerbation, lower and upper respiratory infections accounted for the 71% of the ER visits and 77% of the
hospitalizations. The patients with ER visits were older, had suffered longer from asthma and more frequently from
chronic sinusitis, were more often ex- or current smokers, and had lower lung function parameters compared to
the patients without emergency visits. Previous (HR 1.9, CI 1.3-3.1) and current smoking (HR 3.6, CI 1.6-8.2), poor
self-reported health related quality of life (HRQoL) (HR 2.5, CI 1.5-4), and poor lung function (FEV1 < 65%, HR 2.2,
CI 1.3-3.7) remained independent risk factors for ER visits after adjustment for age and gender.
Conclusions: Asthma patients who are or have been long-term smokers are more likely to require ER care
compared to never smokers.
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Modern pharmaceuticals such as inhaled steroids, long-
acting β2-agonists, their combinations, and leukotriene an-
tagonists have allowed high quality asthma management
[1,2]. The present concept of asthma management is to in-
tensify the treatment until full control has been achieved.
In Finland, asthma management has developed not only
because of efficient medication but also due to a nationwide
educational programme during years 1994–2004 [3]. The
program was focused to improve the patients’ self-
management capabilities by implementation of a self-
management plan, and to update the referral and treatment
networks in primary health care [3]. Improved care was
proven by several indicators, such as decrease in mortality,
disability pensions, and hospital days, and other savings in
health care. Better control of asthma management was also* Correspondence: paula.kauppi@hus.fi
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unless otherwise stated.shown as a decreased proportion of young men exempted
from military service [3,4].
Among younger adults exacerbations requiring hospital-
izations frequently reflect a failure in asthma management.
At older age, however, co-existing chronic diseases are
common [5,6]. Co-morbidities, underdiagnosis and under-
treatment of asthma, and also in turn potential adverse
events due to long-term asthma medication complicate
the treatment of asthma and thus, increase the risk of an
exacerbation [5-7]. Obesity, gastro-oesophageal reflux,
sleep apnoea, hyperlipidemia, diabetes, and osteoporosis
have been associated both to aging and asthma [7,8].
These conditions are also closely related to adverse effects
of corticosteroids. Asthma has also been reported to
double the risk of coronary heart disease [8,9]. Depression
and anxiety are found more often in asthma patients and
further, depression and anxiety are associated with poor
asthma control, long-term work disability, and increase in
emergency treatments [8,10-12]. Many of elderly asthmaLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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versible airway obstruction [13]. Overall, elderly asthma
patients have poorer self-estimated health status com-
pared to that in the age matched general population. Inad-
equate asthma treatment is also more common in older
than in younger age groups [7].
In the present study, we examined the factors that are
associated with emergency visits in an elderly asthma
population. In these events, asthma was the primary
cause or the primary contributing factor of the visit. All
visits due to dyspnea, airway infection, chest discomfort,
or palpitation were included. We concentrated in the
events that require the emergency department and thus,
urgent actions to prevent a serious outcome [14].
Methods
Study population
Adult asthma patients who had visited a Pulmonary Clinic
of a University Hospital during the years 1995–2006 were
invited to a 10 year follow-up study. Recruitment strategy
and diagnostic criteria have been described previously in
detail [13]. A total of 1855 patients participated in the
study. Patients asthma diagnosis was confirmed and a ran-
dom sample the patients (N = 344) were studied in detail
regarding their emergency treatment history. We did a
retrospective comparative study between asthma patients
with emergency visits (N=117, those who had ≥1 emer-
gency visit during the years 1995-2005) and asthma pa-
tients without emergency visits (N=227, patients without
emergency visits). The event free time was accounted for
each patient starting from the diagnosis or year 1995 in
the case diagnosis was made earlier and ending to the first
emergency visit or at the latest year 2005 when the pa-
tients were contacted by the study personnel.
The study population was a random sample (N = 344)
of the original asthma population (N = 1855). In the ori-
ginal cohort the proportion of women was 69%, mean
age at diagnosis 44 years, and at recruitment 55 years.
Assessment of emergency visits
Medical records from all health-care providers that had
treated the patient were merged retrospectively. Referral
diagnoses were used to identify all the ER visits at the
emergency departments of the hospitals open 24/7.
Visits in the primary health care were not included. Dis-
charge diagnosis given by the physician of the emer-
gency department was used to refine the diagnoses. All
visits to the emergency clinics at hospitals open 24/7
due to asthma or respiratory infection were included
into the analysis as the primary endpoint. All the visits
due to upper or lower respiratory or cardiovascular sys-
tems (asthma exacerbation, respiratory infections, car-
diac arrhythmias and palpitations, ischemic heart disease
or heart failure, unspecified dyspnea, chest discomfort orpain) were considered as the asthma-related and were
recognized in the analysis as the ER visit. Information
on age, gender, BMI, smoking history and pack years,
onset of chronic diseases and lung function parameters
[13] were collected with a structured manner. ATS/ERS
guidelines and national reference values were used in in-
terpretation of spirometer results [15,16]. In addition,
the last scheduled contact to health care prior the emer-
gency visit was evaluated.
Assessment of co-morbidities
Information on asthma related conditions (allergic rhinitis,
asetylsalicylic intolerance, atopic eczema, chronic sinusitis,
COPD, and nasal polyps), and other co-morbidities (cardio-
or cerebrovascular disease, diabetes, psychiatric diseases,
and alcohol abuse) were gathered in the medical records.
‘Asthma-COPD overlap’ diagnosis was given those patients
who had first asthma, but who in addition developed per-
sistent irreversible airway obstruction (FEV1/FVC < 70%)
due to long-term smoking [17]. ‘Allergic rhinitis’ was diag-
nosed by a pulmonologist or a rhinologist and was based
on IgE mediated allergy and rhinitis symptoms. ‘Asetylsa-
licylic intolerance’ was diagnosed by a pulmonologist and
was based on positive symptom history. ‘Atopic eczema’
was diagnosed by a pulmonologist or a dermatologist ac-
cording to eczema manifestation on typical skin areas.
‘Chronic sinusitis’ and ‘nasal polyposis’ was diagnosed by a
rhinologist according to clinical symptoms and findings.
Coronary or cerebrovascular disease, or peripheral arterial
occlusive disease were categorized as ‘cardiovascular dis-
ease’. ‘Cerebrovascular disease’ (CVD) was diagnosed by a
neurologist and was based on a stroke, brain haemorrhage
or a transient ischemic attack. ‘Coronary disease’ included
the patients who had been diagnosed with a myocardial in-
farct, an acute coronary syndrome, or angina pectoris by an
internist. Both type I and type II diabetes were categorized
as ‘diabetes’. ‘Psychiatric disorders’ included patients with a
medication for psychotic disorders, depression, or anxiety.
‘Alcohol abuse’ included patients with chronic alcoholism
and treatment because of alcohol related disorder.
Assessment of self-reported information
Self-reported smoking status (never, ex-smoker, current
smoker and pack years) was gathered by a questionnaire. In
addition, health-related quality of life (HRQoL) was mea-
sured with an airway symptom specific questionnaire
(AQ20 questionnaire) including 20 items [18-21]. “Yes”
responses were scored as 1, and “no” and “not applicable”
as 0. The summary score varied from 0 (=no symptoms or
worries over the disease) to 20 (=full range of symptoms
and worries about the disease). The summary scores
were normally distributed among the participants. At
recruitment all participants returned the questionnaire.
Ambiguous or missing responses per question ranged
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cruitment and on average 3.3 (SD 2.9) years after the latest
emergency visit. The patients also reported their working
status (at work, on disability pension, on old-age pension).
The study approach was approved by the Coordinating
Ethics Committee of the Hospital District and the permis-
sion to conduct this research was granted by the Univer-
sity Central Hospital. The study population had given
their written informed consents for the study.Statistical analysis
The SPSS computer package (version 16.0) was used to
compute differences in demographic and clinical vari-
ables. Continuous variables were compared using the
non-parametric Mann–Whitney U –test and categorical
variables using the Chi square test.
All associated clinical variables were included in the
Cox proportional hazard model to determine the inde-
pendent predictors for the first emergency visit. The re-
spective estimated hazard ratios (HR) with confidence
intervals (CI) of 95% are reported. Differences were con-
sidered statistically significant when the p value was less
than 0.05.
Cumulative emergency visit free time (Figure 1)
among asthma patients was stratified according to their
smoking status and adjusted for age, gender, duration of
disease, FEV1 of predicted, chronic sinusitis, and the
number of co-morbidities.Figure 1 Cumulative emergency visits free time among asthma
patients who were current smokers (solid line), ex-smokers
(dotted line) and never smokers (dashed line) using the Cox
regression model adjusted for age, gender, duration of disease,
FEV1, chronic sinusitis, and number of co-morbidities.Results
Frequency of emergency (ER) visits
A random sample (N = 344) of elderly (mean age of
56 years, 70% women) asthma patients of a Pulmonary
Clinic of a University Central Hospital were included in
the analysis. Their asthma related ER visits were
followed through medical records since the asthma diag-
nosis or at the most, for 10 proceeding years (in total
1398 patient years). Altogether 117 patients (34%) had
one or more (range 1–12) asthma related ER visits.
These patients were considered as cases (a mean of 2.5
emergency visits per patient). Ninety-four (80%) of the
cases had 1–2, and 23 (20%) had three or more asthma
related ER visits. During the follow-up, the cases had in
total 295 asthma-related emergency visits, a mean of 0.5
ER visits (range 0–7) per year per patient. The asthma
patients with no asthma-related ER visits during the
follow-up comprised the control group (N = 227).
Differences in clinical characteristics
The patients with ER visits were on average four years
older and had also suffered asthma on average four
years longer than the controls (Table 1). The cases were
more frequently current (14.5% vs 4.0%) or ex-smokers
(38.2% vs 27.1%, p ≤ 0.001 for the trend), reported more
pack years (13.2 vs 8.4, p = 0.02), displayed lower lung
functions in spirometry (mean FEV1 75% vs 87% of pre-
dicted, p < 0.001), and were more frequently diagnosed
with COPD second to asthma (23% vs. 8%, p < 0.001)
than the controls. The mean BMI did not differ statisti-
cally significantly between the groups. A trend of an
excess of co-morbidities (cardiovascular diseases, psy-
chiatric disorders, or alcohol abuse) was found among
cases compared to controls, even though not statisti-
cally significant. Except of chronic sinusitis, asthma as-
sociated allergic conditions such as allergic rhinitis,
ASA intolerance, nasal polyposis, or atopic eczema did
not associate with ER visits.
In the end of the retrospective follow-up, the cases re-
ported poorer respiratory specific HRQoL than the con-
trols (total score 8.9 vs. 6.3, p = 0.001). Further, those
with ≥3 ER visits had lower HRQoL than those with 1–2
visits (total score mean 11.2 vs. 8.3, p = 0.003) and their
PEF values were lower than that among the controls
(71.9% vs. 82.9% of the predicted, p < 0.0.001).
There were no statistically significant differences in
work status between the cases and controls. Among the
cases 39% were in active workforce, 35% were on old-
age, and 21% on disability pension. Among the controls,
the corresponding proportions were 45%, 28%, and 14%,
respectively.
When the participants’ use of health care services
were analysed prior to the ER visit, the last scheduled
visit due to asthma was made an average 115 days
Table 1 Clinical characteristics of the asthma patients who had visited emergency clinic at least once during the
follow-up compared to those who had not
Emergency visit Emergency visit
Clinical characteristics Yes No p-value1
N of patients 117 227
Proportion of women 65.8% 75.3% 0.06
Age at diagnosis (mean ± SD) 42.6 ± 16.2 43.7 ± 17.1 not significant
Age at recruitment (mean ± SD) 58.5 ± 11.8 54.7 ± 12.6 0.006
Duration of asthma, years (mean ± SD) 15.7 ± 14.3 11.1 ± 12.0 0.001
BMI (mean ± SD) 26.8 ± 5.5 26.5 ± 5.6 not significant
Smoking status (%)
never 47.3% 68.9% 0.001(trend)
ex smoker 38.2% 27.1%
current smoker 14.5% 4.0%
Pack years (mean ± SD) 13.2 ± 19.7 8.4 ± 17.4 0.02
COPD as second diagnosis (%) 23.1% 8.4% <0.001
Baseline FEV1 percentage of expected (mean ± SD) 75.3 ± 21.1 86.6 ± 17.2 <0.001
Baseline FVC percentage of expected (mean ± SD) 82.9 ± 17.2 91.3 ± 14.6 <0.001
Baseline PEF percentage of expected (mean ± SD) 80.7 ± 20.3 94.0 ± 19.6 <0.001
Baseline FEV1/FVC ratio (mean ± SD) 73.4 ± 11.8 77.9 ± 10.5 0.001
HRQoL score (mean ± SD) 8.9 ± 4.7 6.3 ± 4.5 <0.001
Proportion (%)of patients with
no co-morbidities 59.8 71.8 0.06
1 co-morbidity 33.3 23.3
≥2 co-morbidities 6.8 4.8
Proportion (%) of patients with co-existing
Cardiovascular disease2 16.2 9.3 0.06
Psychiatric disorder3 21.4 16.3 not significant
Diabetes 3.4 5.7 not significant
Alcohol abuse 7.0 4.0 not significant
Chronic sinusitis 16.1 8.5 0.04
Allergic rhinitis 39.3 35.1 not significant
Allergic exzema 19.3 20.9 not significant
ASA intolerance 10.4 6.6 not significant
Nasal polyposis 10.3 8.0 not significant
1Continuous variables were compared using nonparametric Mann–Whitney U-test and categorical variables using the Chi-Square test.
2Included coronary disease, cerebrovascular disease, and peripheral arterial occlusive disease.
3Medication used.
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made in 64% in specialist care, and in 36% in primary
health care, communal or occupational health care or at
private doctor's office (Table 2). In 93% of the emer-
gency visits, the last control had occurred within one
year prior to the ER visit and no statistically significant
difference was observed between primary health care
and specialist care among those whose latest control
exceeded one year (Table 2).Reasons for ER visits among elderly asthma patients
The reason for the ER visits were analysed by using both
the referral information and the more refined discharge
diagnosis data. According to the both referral and the
discharge diagnoses, the majority of emergency visits
(47.4% and 44.6%, respectively) were due asthma exacer-
bation (Table 3). Asthma exacerbation was also the most
common reason in hospitalizations (N = 168, 57% of all
the visits). 22.4% of the visits were referred to emergency
Table 2 Last scheduled, asthma-related visit in primary health care or in specialist care before the ER visit
Last scheduled visit before the ER visit
<1 year prior N = 250 (%) ≥1 year prior N = 19 (%) TotalN = 269 (%)
Primary health care 88 (35.2) 8 (42.1) 96 (35.7)
Specialist care 162 (64.8) 11 (57.9) 173 (64.3)
Total 250 (100) 19 (100) 269 (100)
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itis or fever. The proportion of infections did not change
in the ER evaluation. 14.1% of the ER visits was estimated
to be of cardiovascular origin (pulmonary embolism,
arrhythmia, ischemic coronary disease, or heart failure).
13% of the visits remained unspecified (dyspnoea, thoracic
pain, hyperventilation, haemoptysis) when the patient was
discharged from the emergency department.
The role of clinical determinants in the occurrence of
ER visits was estimated by using the Cox-regressionTable 3 Referral and discharge diagnoses of the emergency v
Diagnosis Reference visit N = 117 (%)
Referral
Asthma exacerbation 50 (42.7)
Arrhythmias 5 (4.3)
Chest pain 15 (12.8)
Dyspnoea 19 (16.2)
Fever 5 (4.3)
Respiratory infection 17 (14.6)
Sinusitis 5 (4.3)
Other causes 1 (0.9)
Total 117 (100)
Emergency discharge
Asthma exacerbation 50 (42.7 )
Asthma-COPD overlap 6 (5.1)
Pneumonia 11 (9.4)
Unspecified respiratory infection 9 (7.7)
Otitis 1 (0.9)
Sinusitis 4 (3.4)
Dyspnoea 3 (2.6)
Pulmonary embolism 3 (2.6)
Arrhythmia 4 (3.4)
Coronary disease or suspicion 9 (7.7)
Heart failure 1 (0.9)
Thoracic pain 8 (6.8)
Allergic reaction 1 (0.9)
Hyperventilation 4 (3.4)
Haemoptysis 1 (0.9)
Other causes 2 (1.8)
Total 117 (100)analysis. Previous (HR 1.8) and current smoking (HR 3.9)
compared to never smoking, impaired lung functions
(FEV1 < 65%, HR 2.9) compared to normal lung function,
secondary diagnosis of COPD (HR 2.3), and poor HRQoL
(HR 1.4) increased the risk significantly (Table 4). Current
smoking (HR 3.6), poor HRQoL (HR 2.5), and FEV1 < 65%
(HR 2.2) remained independent risk factors for ER visit
when the model was adjusted for gender, duration of
asthma, cardiovascular disease, chronic sinusitis, and
COPD. The ER visit free time was significantly shorterisits made by the asthma patients
All visits N = 295(%) Visits leading to hospitalization N = 168 (%)
140 (47.4) 87 (51.8)
22 (7.5) 4 (2.4)
25 (8.5) 11 (6.5)
40 (13.5) 26 (15.5)
26 (8.8) 15 (8.9)
33 (11.2) 22 (13.1)
7 (2.4) 2 (1.2)
2 (0.7) 1 (0.6)
295 (100) 168 (100)
135 (44.6 ) 86 (51.2)
8 (2.9) 5 (3.0)
22 (8.7) 21 (12.5)
26 (8.6) 12 (7.1)
6 (2.2) 2 (1.2)
12 (4.2) 3 (1.8)
4 (1.9) 2 (1.2)
4 (1.3) 4 (2.4)
20 (6.4) 3 (1.8)
15 (4.8) 10 (5.9)
4 (1.6) 4 (2.4)
11 (3.8) 2 (1.2)
4 (1.3) 1 (0.6)
6 (2.2) 2 (1.2)
2 (0.6) 1 (0.6)
16 (5.4) 10 (6.0)
295 (100) 168 (100)
Table 4 Hazard ratios and their 95% confidence intervals (CI) for patient characteristics that explained emergency visits among the asthma patients by the
Cox regression analyses
N of patiens1 % of patients with emergency visits Crude
HR
95% CI P-value Adjusted
HR
95% CI P-value
Male gender 96 34.2%
Female gender 248 65.8% 0.68 0.46-1.00 0.051 1.11 0.67-1.84 NS
Age until first emergency care visit or at evaluation (increase of 1 year) 1.02 1.00-1.03 0.051 1.01 0.99-1.03 NS
Duration of asthma
<15 years 231 60.0% ref. 1.00 ref. 1.00
>=15 years 100 40.0% 1.06 0.72-1.56 NS 1.29 0.82-2.03 NS
FEV1% of expected
> 80% 164 42.7% ref. 1.00 ref. 1.00
FEV1 65-80% 65 24.5% 1.90 1.16-3.11 0.011 1.57 0.91-2.71 NS
FEV1 < 65% 54 32.7% 2.90 1.85-4.54 <0.001 2.20 1.29-3.74 0.004
Smoking
Never 174 47.3% ref. 1.00 ref. 1.00
Ex-smoker 90 38.2% 1.75 1.14-2.66 0.10 1.86 1.30-3.06 0.015
Current 23 14.5% 3.94 2.20-7.07 <0.001 3.59 1.58-8.15 0.002
AQ_20
score 12 or less 290 74.4% ref. 1.00 ref 1.00
score 13 or more 54 25.6% 2.17 1.41-3.33 <0.001 2.51 1.52-4.15 <0.001
CVD
No 304 83.8% ref. 1.00 ref. 1.00
Yes 40 16.2% 1.47 0.89-2.44 NS 1.61 0.91-2.91 NS
Sinusitis
No 299 83.9% ref. 1.00 ref 1.00
Yes 47 16.1% 1.47 0.87-2.51 NS 1.10 0.60-2.02 NS
COPD as a second diagnosis
No 298 76.9% ref. 1.00 ref 1.00
Yes 48 23.1% 2.32 1.45-3.71 <0.001 0.60 0.29-1.23 NS
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and never smokers (Figure 1).
Discussion
In this hospital-based adult asthma study population, one
third of the patients had had an asthma related ER visit
(mean 0.5 visits per patient per year). Asthma exacerba-
tion and upper or lower respiratory tract infections cov-
ered 72% of the ER visits. Rest of the visits were due to
other respiratory (15%) or cardiovascular events (13%).
57% of the ER visits led to hospitalization of the patient.
The patients with emergency visits had experienced
asthma longer (on average 16 years at the recruitment)
than the control group (on average 11 years), and their
asthma was more severe according to the lung function
test results (FEV1 75% vs. 87% of the predicted, respect-
ively). 59% of the patients with ER visits had been in spe-
cial care prior to the ER visit also reflecting the severity of
asthma. Asthma patients with ER visits were more fre-
quently ex- or current smokers and displayed asthma/
COPD overlapping features. Poor airway specific HRQoL
was associated with the number of ER visits. Current
smoking, poor HRQoL, and moderate to severe airway ob-
struction (FEV1 less than 65%) remained independent risk
factors for ER visits in the cohort.
Since the availability of health care services has an im-
pact on ER visits and our study design was completely
based on retrospective data, the analysis was conducted
only in one hospital district. The number of study sub-
jects was small which decreased variability between the
patients. Also, the small recruitment rate was limited
and it was not possible to analyse further the non-
responders. The follow-up time, however, was 1398 pa-
tient years, which increased the informativeness of the
study design and the robustness of the major findings.
When frequent visitors of ER have been studied in US,
several of them had low income, inadequate medication,
and no written asthma action plan [22]. By the imple-
mentation of the National Asthma Program special at-
tention was paid to improve patients’ capabilities to self-
treatment and to the health care organisations to avoid
simple caps in the asthma treatment. More than 90% of
the ER visitors had had a schedule appointment due to
asthma within a year and 57% of all visits led to hospital
admissions suggesting rather well organised asthma care
in the region.
Asthma and asthma related co-morbidities have shown
to be important determinants of acute care. Co-morbidities
have been associated in 9% of all ER room visits and 6% of
all hospitalisations in asthma [23]. Our study supports the
role of co-morbidities and expands findings on smoking
and the level of bronchus obstruction as risk factors of
emergency care. Current smoking already in mild asthma
has been associated with impaired response to inhaledcorticosteroids [24-26]. With the same dose these patients
report poorer asthma control including more frequent
symptoms and lower peak flow values than their non-
smoking counterparts. Furthermore, smoking cessation has
been reported to gain better lung function in asthmatics
compared to those asthma patients who continue to smoke
[24-26]. Differential diagnostics with other conditions and
overlap with COPD has been previously reported as a chal-
lenge for diagnosis of asthma, while co-morbidities being
more of a challenge for asthma management [5].
The importance of obstruction was shown also in a pro-
spective study of 554 asthma patients (18-55 years of age)
identified from a large health maintenance organization.
The patients were followed for 30 months to identify risks
for acute care. The strongest predictors were airflow ob-
struction (RR 4.3 when FEV1<60%) and again, current
smoking (RR 1.6) [27]. Typically spirometer measure-
ments are performed when the patient is at his best, not
during the exacerbations. Thus most likely declined spir-
ometer values reflected permanent loss of lung function
among this patient group. Whether the ER visit resulted
due to severe disease or insufficient medication can not be
determined without detailed information on used asthma
medication. Other risk factors were regular exposure to
solvents and the ownership of dog or cat when being skin-
prick test positive. In the present older and hospital based
patient cohort, allergic rhinitis or atopic eczema did not
did not associate with ER visits or hospitalizations.
Allergen sensitation and exposure with simultaneous
viral infection have been reported to increase the risk (OR
8.4) of hospital admissions among adult asthma patients
[28]. In the present study chronic sinusitis increased the
risk and acute infections explained one fourth of all visits.
Tobacco smoke has been shown to increase viral replica-
tion [29,30] while inhaled corticosteroids protect against
rhinovirus induced airway inflammation but not against
viral replication which might partly explain poor treat-
ment response among smokers [31]. The cases had more
common co-morbidities, but compared to infections for
example the significance of cardiovascular disease was
much less, 13% of the visits. Diabetes, psychiatric disor-
ders, and alcohol abuse, even though common risk factors
of poorer control of asthma and acute care, were not in-
creased in the ER-group (Table 1). Many co-morbidities
such as anxiety and depression also have an impact on
HRQoL and poor HRQoL on the other hand is a risk fac-
tor for ER visits [22,32,33]. Poor HRQoL also associates
with known asthma triggers such as respiratory infections,
environmental irritants, emotions, allergens, weather, and
exercise. The patients who need acute care have fre-
quently multiple triggers [34].
Recently, increase in severity of asthma has been sug-
gested to be associated with an increase of obesity [35].
Obesity is associated with gastroesophageal reflux
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worsen the asthma symptoms [9]. In the study of Mosen
et al. obese individuals with persistent asthma reported
more frequently poorer asthma-related quality of life
and more asthma-related hospitalisations than patients
with normal weight [36]. Obesity remained an independ-
ent risk for hospitalizations after adjustment for age, sex,
smoking status, use of corticosteroids, and gastroesopha-
geal reflux disease. In present cohort, the BMI did not
differ between the cases and controls which may be
partly due to the relatively small study size.
Conclusions
The majority of the ER visits in adult asthma were directly
due to asthma exacerbation or respiratory infections indi-
cating the importance of the education of the patients.
They should have the means to recognise the symptoms
early on and adapt their self-management plan accord-
ingly. Smoking cessation plays the key role in the mainten-
ance of normal pulmonary function and prevention of
emergency care.
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